Branquinho, M, Rodriguez-Muñoz, MF, Maia, BR, et al. Effectiveness of psychological interventions in the treatment of perinatal depression: a systematic review of systematic reviews and meta-analyses. J Affect Disord 2021; 291:294–306CrossRefGoogle ScholarPubMed

Brooks, E, Cox, E, Kimmel, M, et al. Risk of Untreated Symptoms of PMADs in Pregnancy and Lactation. Cham, Switzerland: Springer, 2021, 45–54Google Scholar

Byatt, N, Deligiannidis, KM, Freeman, MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand 2013; 127:94–114CrossRefGoogle ScholarPubMed

Chad, L, Pupco, A, Bozzo, P, et al. Update on antidepressant use during breastfeeding. Can Fam Physician 2013; 59:633–4Google ScholarPubMed

Dean, L, Kane, M. Aripiprazole therapy and CYP2D6 genotype. Sept. 22, 2016 [Updated Feb. 10, 2021]. In: Pratt VM, Scott SA, Pirmohamed M, et al. (eds.) Medical Genetics Summaries [internet]. Bethesda, MD): National Center for Biotechnology Information (US); 2012– ; www.ncbi.nlm.nih.gov/books/NBK385288Google Scholar

Deligiannidis, KM, Freeman, MP. Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol 2014; 28:85–95CrossRefGoogle ScholarPubMed

El Marroun, H, Jaddoe, VW, Hudziak, JJ, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; 69:706–14CrossRefGoogle ScholarPubMed

Eléfant, E, Hanin, C, Cohen, D. Pregnant women, prescription, and fetal risk. Handb Clin Neurol 2020; 173:377–89CrossRefGoogle ScholarPubMed

Gadot, Y, Koren, G. The use of antidepressants in pregnancy: focus on maternal risks. J Obstet Gynaecol Can 2015; 37:56–63Google ScholarPubMed

Galbally, M, Lewis, AJ, Buist, A. Developmental outcomes of children exposed to antidepressants in pregnancy. Aust N Z J Psychiatry 2011; 45:393–9CrossRefGoogle ScholarPubMed

Hashmi, AM, Bhatia, SK, Bhatia, SK, et al. Insomnia during pregnancy: diagnosis and rational interventions. Pak J Med Sci 2016; 32:1030–7Google ScholarPubMed

Huybrechts, KF, Bateman, BT, Palmsten, K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 2015; 313:2142–51CrossRefGoogle ScholarPubMed

Huybrechts, KF, Palmsten, K, Avorn, J, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014; 370:2397–407CrossRefGoogle ScholarPubMed

Kjaersgaard, MIS, Parner, ET, Vestergaard, M, et al. Prenatal antidepressant exposure and risk of spontaneous abortion – a population-based study. PLoS One 2013; 8:e72095CrossRefGoogle ScholarPubMed

Lee, HJ, Kim, SM, Kwon, JY. Repetitive transcranial magnetic stimulation treatment for peripartum depression: systematic review & meta-analysis. BMC Pregnancy and Childbirth 2021; 21:118CrossRefGoogle ScholarPubMed

Levinson-Castiel, R, Merlob, P, Linder, N, et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173–6CrossRefGoogle ScholarPubMed

Lomonaco-Haycraft, KC, Hyer, J, Tibbits, B, et al. Integrated perinatal mental health care: a national model of perinatal primary care in vulnerable populations. Prim Health Care Res Dev 2018; 20:e77CrossRefGoogle ScholarPubMed

Malm, H, Brown, AS, Gissler, M, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry 2016; 55:359–66Google ScholarPubMed

Nelson, JC, Pikalov, A, Berman, RM. Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatr Dis Treat 2008; 4:937–48Google ScholarPubMed

Osborne, L, Birndorf, C. Depressive Disorders. Arlington, VA: American Psychiatric Publishing, Inc., 2022.Google Scholar

Patorno, E, Huybrechts, KF, Bateman, BT, et al. Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 2017; 376:2245–54. https://doi.org/10.1056/NEJMoa1612222CrossRefGoogle ScholarPubMed

Payne, JL. Psychopharmacology in pregnancy and breastfeeding. Psychiatr Clin North Am 2017; 40:217–38CrossRefGoogle ScholarPubMed

Payne, JL. Psychopharmacology in pregnancy and breastfeeding. Med Clin North Am 2019; 103:629–50CrossRefGoogle ScholarPubMed

Rommel, AS, Momen, NC, Molenaar, NM, et al. Antidepressant use during pregnancy and risk of adverse neonatal outcomes: a comprehensive investigation of previously identified associations. Acta Psychiatr Scand 2022; 145:544–56CrossRefGoogle ScholarPubMed

Ross, LE, Grigoriadis, S, Mamisashvili, L, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 2013; 70:436–43CrossRefGoogle ScholarPubMed

Van den Bergh, BR, Van Calster, B, Smits, T, et al. Antenatal maternal anxiety is related to HPA-axis dysregulation and self-reported depressive symptoms in adolescence: a prospective study on the fetal origins of depressed mood. Neuropsychopharmacology 2008; 33:536–45Google ScholarPubMed

Ward, HB, Fromson, JA, Cooper, JJ, et al. Recommendations for the use of ECT in pregnancy: literature review and proposed clinical protocol. Arch Womens Ment Health 2018; 21:715–22Google ScholarPubMed

Wisner, KL, Bogen, DL, Sit, D, et al. Does fetal exposure to SSRIs or maternal depression impact infant growth? Am J Psychiatry 2013; 170:485–93CrossRefGoogle ScholarPubMed

Yonkers, KA, Norwitz, ER, Smith, MV, et al. Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. Epidemiology 2012; 23:677–85CrossRefGoogle ScholarPubMed